Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Wormsley

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
The Journal of Biological Chemistry|April 5, 2000
Fibrillarin-associated box C/D small nucleolar RNAs in Trypanosoma brucei. Sequence conservation and implications for 2'-O-ribose methylation of rRNAD A Dunbar, S Wormsley, T M Lowe, et al.
Leukemia Research|January 1, 1991
Hybrid leukemia and the 5q-abnormalityG Sun, S Wormsley, R S Sparkes, et al.
Nucleic Acids Symposium Series|January 1, 1997
Mpp10p, a new protein component of the U3 snoRNP required for processing of 18S rRNA precursorsS J Baserga, T M Agentis, S Wormsley, et al.
Leukemia & Lymphoma|June 1, 1996
New perspectives on the approach to chronic lymphocytic leukemiaM G Goodman, J C Spinosa, A Saven, et al.
Comparative Biochemistry and Physiology. B, Comparative Biochemistry|January 1, 1978
Immunological cross-reactions between heterologous hemopexinsK H Cox, S Wormsley, N A Northway, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1984
Deoxyadenosine (AdR) inhibition of newly activated lymphocytes: blockade at the G0-G1 interfaceD Redelman, H G Bluestein, A H Cohen, et al.
Leukemia Research|January 1, 1991
Where does transformation occur in acute leukemia?G X Sun, S Wormsley, R S Sparkes, et al.
Clinical and Experimental Immunology|April 1, 1995
Autoproliferation in HIV-1-infected patients undergoing active HIV-1-specific immunotherapyR J Trauger, W Giermakowska, S Wormsley, et al.
Cancer Genetics and Cytogenetics|October 15, 1990
Are some cases of acute leukemia with t(8;21) hybrid leukemias?G X Sun, R S Sparkes, S Wormsley, et al.
Journal of Biological Response Modifiers|January 1, 1983
In vivo immune restoration in advanced cancer patients after administration of thymosin fraction 5 or thymosin alpha 1R O Dillman, J C Beauregard, M I Zavanelli, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
The Journal of Biological Chemistry|April 5, 2000
Fibrillarin-associated box C/D small nucleolar RNAs in Trypanosoma brucei. Sequence conservation and implications for 2'-O-ribose methylation of rRNAD A Dunbar, S Wormsley, T M Lowe, et al.
Leukemia Research|January 1, 1991
Hybrid leukemia and the 5q-abnormalityG Sun, S Wormsley, R S Sparkes, et al.
Nucleic Acids Symposium Series|January 1, 1997
Mpp10p, a new protein component of the U3 snoRNP required for processing of 18S rRNA precursorsS J Baserga, T M Agentis, S Wormsley, et al.
Leukemia & Lymphoma|June 1, 1996
New perspectives on the approach to chronic lymphocytic leukemiaM G Goodman, J C Spinosa, A Saven, et al.
Comparative Biochemistry and Physiology. B, Comparative Biochemistry|January 1, 1978
Immunological cross-reactions between heterologous hemopexinsK H Cox, S Wormsley, N A Northway, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1984
Deoxyadenosine (AdR) inhibition of newly activated lymphocytes: blockade at the G0-G1 interfaceD Redelman, H G Bluestein, A H Cohen, et al.
Leukemia Research|January 1, 1991
Where does transformation occur in acute leukemia?G X Sun, S Wormsley, R S Sparkes, et al.
Clinical and Experimental Immunology|April 1, 1995
Autoproliferation in HIV-1-infected patients undergoing active HIV-1-specific immunotherapyR J Trauger, W Giermakowska, S Wormsley, et al.
Cancer Genetics and Cytogenetics|October 15, 1990
Are some cases of acute leukemia with t(8;21) hybrid leukemias?G X Sun, R S Sparkes, S Wormsley, et al.
Journal of Biological Response Modifiers|January 1, 1983
In vivo immune restoration in advanced cancer patients after administration of thymosin fraction 5 or thymosin alpha 1R O Dillman, J C Beauregard, M I Zavanelli, et al.
Pageof 3